BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Aurinia (Formerly Known as Isotechnika Pharma Inc.) 

5120 - 75th Street

Edmonton  Alberta  T6E 6W2  Canada
Phone: 780-487-1600 Fax: 780-484-4105


SEARCH JOBS

View Clinical Trials from BioPharm Insight









 Company News
Aurinia (ISA.TO) To Present At The 2015 UBS Global Health Care Conference 5/20/2015 8:04:30 AM
Aurinia (ISA.TO) Reports First Quarter 2015 Financial Results And Restatement Of 2014 Financial Statements 5/18/2015 11:43:30 AM
Aurinia (ISA.TO) To Host Lupus Nephritis Opinion Leader Meeting And Webcast On May 5 In New York 4/23/2015 7:39:08 PM
Aurinia (ISA.TO) Reports Fourth Quarter And Full Year 2014 Financial Results And Highlights Initiation Of Its Open Label Clinical Study To Investigate The Impact Of Voclosporin On Lupus Nephritis Biomarkers 3/31/2015 2:35:44 PM
Aurinia (ISA.TO) Announces Change To Its Board of Directors 3/9/2015 11:08:12 AM
Aurinia (ISA.TO) To Present At Cowen and Company 35th Annual Health Care Conference 2/27/2015 11:28:00 AM
Aurinia (ISA.TO) To Initiate An Open Label Clinical Study To Investigate The Impact Of Voclosporin On Lupus Nephritis Biomarkers 2/9/2015 8:47:27 AM
Aurinia (ISA.TO) Announces Recently Granted Nanomicellar Formulation Patents In Japan And China For Topical Ophthalmic Administration Of Voclosporin 2/4/2015 8:24:58 AM
Aurinia (ISA.TO) Reports Third Quarter 2014 Financial Results 11/12/2014 8:06:20 AM
Aurinia (ISA.TO) To Host Lupus Opinion Leader Meeting And Webcast On October 23 In New York City 10/21/2014 6:27:59 AM
12345678910...